▶ 調査レポート

ラジオイムノアッセイの世界市場(~2026年)

• 英文タイトル:Global Radioimmunoassays Market Size, Status and Forecast 2020-2026

QYResearchが調査・発行した産業分析レポートです。ラジオイムノアッセイの世界市場(~2026年) / Global Radioimmunoassays Market Size, Status and Forecast 2020-2026 / MRC2-11QY04443資料のイメージです。• レポートコード:MRC2-11QY04443
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、127ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:ヘルスケア
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料はラジオイムノアッセイのグローバル市場について調査・分析したレポートです。種類別(バランス法、シーケンシャルサチュレーション法)市場規模、用途別(製薬、医療検査、腫瘍、その他)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別ラジオイムノアッセイの競争状況、市場シェア
・世界のラジオイムノアッセイ市場:種類別市場規模 2015年-2020年(バランス法、シーケンシャルサチュレーション法)
・世界のラジオイムノアッセイ市場:種類別市場規模予測 2021年-2026年(バランス法、シーケンシャルサチュレーション法)
・世界のラジオイムノアッセイ市場:用途別市場規模 2015年-2020年(製薬、医療検査、腫瘍、その他)
・世界のラジオイムノアッセイ市場:用途別市場規模予測 2021年-2026年(製薬、医療検査、腫瘍、その他)
・北米のラジオイムノアッセイ市場分析:米国、カナダ
・ヨーロッパのラジオイムノアッセイ市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアのラジオイムノアッセイ市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米のラジオイムノアッセイ市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカのラジオイムノアッセイ市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Immunoshop India Pvt Ltd.、Institute Of Isotopes Co. Ltd、Instrumentation Laboratory Co.、Novartis Vaccines & Diagnostics Inc.、Sysmex、Trinity Biotech Plc、Weifang 3v Bioengineering Group Co. Ltd.、Weifang Kanghua Biotech Co. Ltd.、Abbott Diagnostics、Acon Laboratories Inc.、Amar Immunodiagnostics、Bayer Ag、Beckman Coulter Inc.、Xiamen Boson Biotech Co. Ltd.、Jei Daniel Biotech Corp.、Labor Diagnostika Nord Gmbh & Co. Kg、Micropoint Bioscience Inc.
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Radioimmunoassays Market
The global Radioimmunoassays market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Radioimmunoassays Scope and Market Size
Radioimmunoassays market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Radioimmunoassays market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

The key players covered in this study
Immunoshop India Pvt Ltd.
Institute Of Isotopes Co. Ltd
Instrumentation Laboratory Co.
Novartis Vaccines & Diagnostics Inc.
Sysmex
Trinity Biotech Plc
Weifang 3v Bioengineering Group Co. Ltd.
Weifang Kanghua Biotech Co. Ltd.
Abbott Diagnostics
Acon Laboratories Inc.
Amar Immunodiagnostics
Bayer Ag
Beckman Coulter Inc.
Xiamen Boson Biotech Co. Ltd.
Jei Daniel Biotech Corp.
Labor Diagnostika Nord Gmbh & Co. Kg
Micropoint Bioscience Inc.

Market segment by Type, the product can be split into
Balance Method
Sequential Saturation Method
Market segment by Application, split into
Pharmaceutical
Medical Testing
Onology
Others

Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Radioimmunoassays Revenue
1.4 Market by Type
1.4.1 Global Radioimmunoassays Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Balance Method
1.4.3 Sequential Saturation Method
1.5 Market by Application
1.5.1 Global Radioimmunoassays Market Share by Application: 2020 VS 2026
1.5.2 Pharmaceutical
1.5.3 Medical Testing
1.5.4 Onology
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Global Radioimmunoassays Market Perspective (2015-2026)
2.2 Global Radioimmunoassays Growth Trends by Regions
2.2.1 Radioimmunoassays Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Radioimmunoassays Historic Market Share by Regions (2015-2020)
2.2.3 Radioimmunoassays Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Radioimmunoassays Market Growth Strategy
2.3.6 Primary Interviews with Key Radioimmunoassays Players (Opinion Leaders)

3 Competition Landscape by Key Players
3.1 Global Top Radioimmunoassays Players by Market Size
3.1.1 Global Top Radioimmunoassays Players by Revenue (2015-2020)
3.1.2 Global Radioimmunoassays Revenue Market Share by Players (2015-2020)
3.1.3 Global Radioimmunoassays Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Radioimmunoassays Market Concentration Ratio
3.2.1 Global Radioimmunoassays Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Radioimmunoassays Revenue in 2019
3.3 Radioimmunoassays Key Players Head office and Area Served
3.4 Key Players Radioimmunoassays Product Solution and Service
3.5 Date of Enter into Radioimmunoassays Market
3.6 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Radioimmunoassays Historic Market Size by Type (2015-2020)
4.2 Global Radioimmunoassays Forecasted Market Size by Type (2021-2026)

5 Market Size by Application (2015-2026)
5.1 Global Radioimmunoassays Market Size by Application (2015-2020)
5.2 Global Radioimmunoassays Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Radioimmunoassays Market Size (2015-2020)
6.2 Radioimmunoassays Key Players in North America (2019-2020)
6.3 North America Radioimmunoassays Market Size by Type (2015-2020)
6.4 North America Radioimmunoassays Market Size by Application (2015-2020)

7 Europe
7.1 Europe Radioimmunoassays Market Size (2015-2020)
7.2 Radioimmunoassays Key Players in Europe (2019-2020)
7.3 Europe Radioimmunoassays Market Size by Type (2015-2020)
7.4 Europe Radioimmunoassays Market Size by Application (2015-2020)

8 China
8.1 China Radioimmunoassays Market Size (2015-2020)
8.2 Radioimmunoassays Key Players in China (2019-2020)
8.3 China Radioimmunoassays Market Size by Type (2015-2020)
8.4 China Radioimmunoassays Market Size by Application (2015-2020)

9 Japan
9.1 Japan Radioimmunoassays Market Size (2015-2020)
9.2 Radioimmunoassays Key Players in Japan (2019-2020)
9.3 Japan Radioimmunoassays Market Size by Type (2015-2020)
9.4 Japan Radioimmunoassays Market Size by Application (2015-2020)

10 Southeast Asia
10.1 Southeast Asia Radioimmunoassays Market Size (2015-2020)
10.2 Radioimmunoassays Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Radioimmunoassays Market Size by Type (2015-2020)
10.4 Southeast Asia Radioimmunoassays Market Size by Application (2015-2020)

11 India
11.1 India Radioimmunoassays Market Size (2015-2020)
11.2 Radioimmunoassays Key Players in India (2019-2020)
11.3 India Radioimmunoassays Market Size by Type (2015-2020)
11.4 India Radioimmunoassays Market Size by Application (2015-2020)

12 Central & South America
12.1 Central & South America Radioimmunoassays Market Size (2015-2020)
12.2 Radioimmunoassays Key Players in Central & South America (2019-2020)
12.3 Central & South America Radioimmunoassays Market Size by Type (2015-2020)
12.4 Central & South America Radioimmunoassays Market Size by Application (2015-2020)

13 Key Players Profiles
13.1 Immunoshop India Pvt Ltd.
13.1.1 Immunoshop India Pvt Ltd. Company Details
13.1.2 Immunoshop India Pvt Ltd. Business Overview
13.1.3 Immunoshop India Pvt Ltd. Radioimmunoassays Introduction
13.1.4 Immunoshop India Pvt Ltd. Revenue in Radioimmunoassays Business (2015-2020))
13.1.5 Immunoshop India Pvt Ltd. Recent Development
13.2 Institute Of Isotopes Co. Ltd
13.2.1 Institute Of Isotopes Co. Ltd Company Details
13.2.2 Institute Of Isotopes Co. Ltd Business Overview
13.2.3 Institute Of Isotopes Co. Ltd Radioimmunoassays Introduction
13.2.4 Institute Of Isotopes Co. Ltd Revenue in Radioimmunoassays Business (2015-2020)
13.2.5 Institute Of Isotopes Co. Ltd Recent Development
13.3 Instrumentation Laboratory Co.
13.3.1 Instrumentation Laboratory Co. Company Details
13.3.2 Instrumentation Laboratory Co. Business Overview
13.3.3 Instrumentation Laboratory Co. Radioimmunoassays Introduction
13.3.4 Instrumentation Laboratory Co. Revenue in Radioimmunoassays Business (2015-2020)
13.3.5 Instrumentation Laboratory Co. Recent Development
13.4 Novartis Vaccines & Diagnostics Inc.
13.4.1 Novartis Vaccines & Diagnostics Inc. Company Details
13.4.2 Novartis Vaccines & Diagnostics Inc. Business Overview
13.4.3 Novartis Vaccines & Diagnostics Inc. Radioimmunoassays Introduction
13.4.4 Novartis Vaccines & Diagnostics Inc. Revenue in Radioimmunoassays Business (2015-2020)
13.4.5 Novartis Vaccines & Diagnostics Inc. Recent Development
13.5 Sysmex
13.5.1 Sysmex Company Details
13.5.2 Sysmex Business Overview
13.5.3 Sysmex Radioimmunoassays Introduction
13.5.4 Sysmex Revenue in Radioimmunoassays Business (2015-2020)
13.5.5 Sysmex Recent Development
13.6 Trinity Biotech Plc
13.6.1 Trinity Biotech Plc Company Details
13.6.2 Trinity Biotech Plc Business Overview
13.6.3 Trinity Biotech Plc Radioimmunoassays Introduction
13.6.4 Trinity Biotech Plc Revenue in Radioimmunoassays Business (2015-2020)
13.6.5 Trinity Biotech Plc Recent Development
13.7 Weifang 3v Bioengineering Group Co. Ltd.
13.7.1 Weifang 3v Bioengineering Group Co. Ltd. Company Details
13.7.2 Weifang 3v Bioengineering Group Co. Ltd. Business Overview
13.7.3 Weifang 3v Bioengineering Group Co. Ltd. Radioimmunoassays Introduction
13.7.4 Weifang 3v Bioengineering Group Co. Ltd. Revenue in Radioimmunoassays Business (2015-2020)
13.7.5 Weifang 3v Bioengineering Group Co. Ltd. Recent Development
13.8 Weifang Kanghua Biotech Co. Ltd.
13.8.1 Weifang Kanghua Biotech Co. Ltd. Company Details
13.8.2 Weifang Kanghua Biotech Co. Ltd. Business Overview
13.8.3 Weifang Kanghua Biotech Co. Ltd. Radioimmunoassays Introduction
13.8.4 Weifang Kanghua Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2015-2020)
13.8.5 Weifang Kanghua Biotech Co. Ltd. Recent Development
13.9 Abbott Diagnostics
13.9.1 Abbott Diagnostics Company Details
13.9.2 Abbott Diagnostics Business Overview
13.9.3 Abbott Diagnostics Radioimmunoassays Introduction
13.9.4 Abbott Diagnostics Revenue in Radioimmunoassays Business (2015-2020)
13.9.5 Abbott Diagnostics Recent Development
13.10 Acon Laboratories Inc.
13.10.1 Acon Laboratories Inc. Company Details
13.10.2 Acon Laboratories Inc. Business Overview
13.10.3 Acon Laboratories Inc. Radioimmunoassays Introduction
13.10.4 Acon Laboratories Inc. Revenue in Radioimmunoassays Business (2015-2020)
13.10.5 Acon Laboratories Inc. Recent Development
13.11 Amar Immunodiagnostics
10.11.1 Amar Immunodiagnostics Company Details
10.11.2 Amar Immunodiagnostics Business Overview
10.11.3 Amar Immunodiagnostics Radioimmunoassays Introduction
10.11.4 Amar Immunodiagnostics Revenue in Radioimmunoassays Business (2015-2020)
10.11.5 Amar Immunodiagnostics Recent Development
13.12 Bayer Ag
10.12.1 Bayer Ag Company Details
10.12.2 Bayer Ag Business Overview
10.12.3 Bayer Ag Radioimmunoassays Introduction
10.12.4 Bayer Ag Revenue in Radioimmunoassays Business (2015-2020)
10.12.5 Bayer Ag Recent Development
13.13 Beckman Coulter Inc.
10.13.1 Beckman Coulter Inc. Company Details
10.13.2 Beckman Coulter Inc. Business Overview
10.13.3 Beckman Coulter Inc. Radioimmunoassays Introduction
10.13.4 Beckman Coulter Inc. Revenue in Radioimmunoassays Business (2015-2020)
10.13.5 Beckman Coulter Inc. Recent Development
13.14 Xiamen Boson Biotech Co. Ltd.
10.14.1 Xiamen Boson Biotech Co. Ltd. Company Details
10.14.2 Xiamen Boson Biotech Co. Ltd. Business Overview
10.14.3 Xiamen Boson Biotech Co. Ltd. Radioimmunoassays Introduction
10.14.4 Xiamen Boson Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2015-2020)
10.14.5 Xiamen Boson Biotech Co. Ltd. Recent Development
13.15 Jei Daniel Biotech Corp.
10.15.1 Jei Daniel Biotech Corp. Company Details
10.15.2 Jei Daniel Biotech Corp. Business Overview
10.15.3 Jei Daniel Biotech Corp. Radioimmunoassays Introduction
10.15.4 Jei Daniel Biotech Corp. Revenue in Radioimmunoassays Business (2015-2020)
10.15.5 Jei Daniel Biotech Corp. Recent Development
13.16 Labor Diagnostika Nord Gmbh & Co. Kg
10.16.1 Labor Diagnostika Nord Gmbh & Co. Kg Company Details
10.16.2 Labor Diagnostika Nord Gmbh & Co. Kg Business Overview
10.16.3 Labor Diagnostika Nord Gmbh & Co. Kg Radioimmunoassays Introduction
10.16.4 Labor Diagnostika Nord Gmbh & Co. Kg Revenue in Radioimmunoassays Business (2015-2020)
10.16.5 Labor Diagnostika Nord Gmbh & Co. Kg Recent Development
13.17 Micropoint Bioscience Inc.
10.17.1 Micropoint Bioscience Inc. Company Details
10.17.2 Micropoint Bioscience Inc. Business Overview
10.17.3 Micropoint Bioscience Inc. Radioimmunoassays Introduction
10.17.4 Micropoint Bioscience Inc. Revenue in Radioimmunoassays Business (2015-2020)
10.17.5 Micropoint Bioscience Inc. Recent Development

14 Analyst’s Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List of Tables
Table 1. Radioimmunoassays Key Market Segments
Table 2. Key Players Covered: Ranking by Radioimmunoassays Revenue
Table 3. Ranking of Global Top Radioimmunoassays Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Radioimmunoassays Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Balance Method
Table 6. Key Players of Sequential Saturation Method
Table 7. Global Radioimmunoassays Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Radioimmunoassays Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Radioimmunoassays Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Radioimmunoassays Market Share by Regions (2015-2020)
Table 11. Global Radioimmunoassays Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Radioimmunoassays Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Radioimmunoassays Market Growth Strategy
Table 17. Main Points Interviewed from Key Radioimmunoassays Players
Table 18. Global Radioimmunoassays Revenue by Players (2015-2020) (Million US$)
Table 19. Global Radioimmunoassays Market Share by Players (2015-2020)
Table 20. Global Top Radioimmunoassays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunoassays as of 2019)
Table 21. Global Radioimmunoassays by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Radioimmunoassays Product Solution and Service
Table 24. Date of Enter into Radioimmunoassays Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 27. Global Radioimmunoassays Market Size Share by Type (2015-2020)
Table 28. Global Radioimmunoassays Revenue Market Share by Type (2021-2026)
Table 29. Global Radioimmunoassays Market Size Share by Application (2015-2020)
Table 30. Global Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 31. Global Radioimmunoassays Market Size Share by Application (2021-2026)
Table 32. North America Key Players Radioimmunoassays Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Radioimmunoassays Market Share (2019-2020)
Table 34. North America Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 35. North America Radioimmunoassays Market Share by Type (2015-2020)
Table 36. North America Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 37. North America Radioimmunoassays Market Share by Application (2015-2020)
Table 38. Europe Key Players Radioimmunoassays Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Radioimmunoassays Market Share (2019-2020)
Table 40. Europe Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Radioimmunoassays Market Share by Type (2015-2020)
Table 42. Europe Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Radioimmunoassays Market Share by Application (2015-2020)
Table 44. China Key Players Radioimmunoassays Revenue (2019-2020) (Million US$)
Table 45. China Key Players Radioimmunoassays Market Share (2019-2020)
Table 46. China Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 47. China Radioimmunoassays Market Share by Type (2015-2020)
Table 48. China Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 49. China Radioimmunoassays Market Share by Application (2015-2020)
Table 50. Japan Key Players Radioimmunoassays Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Radioimmunoassays Market Share (2019-2020)
Table 52. Japan Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Radioimmunoassays Market Share by Type (2015-2020)
Table 54. Japan Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Radioimmunoassays Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Radioimmunoassays Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Radioimmunoassays Market Share (2019-2020)
Table 58. Southeast Asia Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Radioimmunoassays Market Share by Type (2015-2020)
Table 60. Southeast Asia Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Radioimmunoassays Market Share by Application (2015-2020)
Table 62. India Key Players Radioimmunoassays Revenue (2019-2020) (Million US$)
Table 63. India Key Players Radioimmunoassays Market Share (2019-2020)
Table 64. India Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 65. India Radioimmunoassays Market Share by Type (2015-2020)
Table 66. India Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 67. India Radioimmunoassays Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Radioimmunoassays Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Radioimmunoassays Market Share (2019-2020)
Table 70. Central & South America Radioimmunoassays Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Radioimmunoassays Market Share by Type (2015-2020)
Table 72. Central & South America Radioimmunoassays Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Radioimmunoassays Market Share by Application (2015-2020)
Table 74. Immunoshop India Pvt Ltd. Company Details
Table 75. Immunoshop India Pvt Ltd. Business Overview
Table 76. Immunoshop India Pvt Ltd. Product
Table 77. Immunoshop India Pvt Ltd. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 78. Immunoshop India Pvt Ltd. Recent Development
Table 79. Institute Of Isotopes Co. Ltd Company Details
Table 80. Institute Of Isotopes Co. Ltd Business Overview
Table 81. Institute Of Isotopes Co. Ltd Product
Table 82. Institute Of Isotopes Co. Ltd Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 83. Institute Of Isotopes Co. Ltd Recent Development
Table 84. Instrumentation Laboratory Co. Company Details
Table 85. Instrumentation Laboratory Co. Business Overview
Table 86. Instrumentation Laboratory Co. Product
Table 87. Instrumentation Laboratory Co. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 88. Instrumentation Laboratory Co. Recent Development
Table 89. Novartis Vaccines & Diagnostics Inc. Company Details
Table 90. Novartis Vaccines & Diagnostics Inc. Business Overview
Table 91. Novartis Vaccines & Diagnostics Inc. Product
Table 92. Novartis Vaccines & Diagnostics Inc. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 93. Novartis Vaccines & Diagnostics Inc. Recent Development
Table 94. Sysmex Company Details
Table 95. Sysmex Business Overview
Table 96. Sysmex Product
Table 97. Sysmex Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 98. Sysmex Recent Development
Table 99. Trinity Biotech Plc Company Details
Table 100. Trinity Biotech Plc Business Overview
Table 101. Trinity Biotech Plc Product
Table 102. Trinity Biotech Plc Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 103. Trinity Biotech Plc Recent Development
Table 104. Weifang 3v Bioengineering Group Co. Ltd. Company Details
Table 105. Weifang 3v Bioengineering Group Co. Ltd. Business Overview
Table 106. Weifang 3v Bioengineering Group Co. Ltd. Product
Table 107. Weifang 3v Bioengineering Group Co. Ltd. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 108. Weifang 3v Bioengineering Group Co. Ltd. Recent Development
Table 109. Weifang Kanghua Biotech Co. Ltd. Business Overview
Table 110. Weifang Kanghua Biotech Co. Ltd. Product
Table 111. Weifang Kanghua Biotech Co. Ltd. Company Details
Table 112. Weifang Kanghua Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 113. Weifang Kanghua Biotech Co. Ltd. Recent Development
Table 114. Abbott Diagnostics Company Details
Table 115. Abbott Diagnostics Business Overview
Table 116. Abbott Diagnostics Product
Table 117. Abbott Diagnostics Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 118. Abbott Diagnostics Recent Development
Table 119. Acon Laboratories Inc. Company Details
Table 120. Acon Laboratories Inc. Business Overview
Table 121. Acon Laboratories Inc. Product
Table 122. Acon Laboratories Inc. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 123. Acon Laboratories Inc. Recent Development
Table 124. Amar Immunodiagnostics Company Details
Table 125. Amar Immunodiagnostics Business Overview
Table 126. Amar Immunodiagnostics Product
Table 127. Amar Immunodiagnostics Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 128. Amar Immunodiagnostics Recent Development
Table 129. Bayer Ag Company Details
Table 130. Bayer Ag Business Overview
Table 131. Bayer Ag Product
Table 132. Bayer Ag Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 133. Bayer Ag Recent Development
Table 134. Beckman Coulter Inc. Company Details
Table 135. Beckman Coulter Inc. Business Overview
Table 136. Beckman Coulter Inc. Product
Table 137. Beckman Coulter Inc. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 138. Beckman Coulter Inc. Recent Development
Table 139. Xiamen Boson Biotech Co. Ltd. Company Details
Table 140. Xiamen Boson Biotech Co. Ltd. Business Overview
Table 141. Xiamen Boson Biotech Co. Ltd. Product
Table 142. Xiamen Boson Biotech Co. Ltd. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 143. Xiamen Boson Biotech Co. Ltd. Recent Development
Table 144. Jei Daniel Biotech Corp. Company Details
Table 145. Jei Daniel Biotech Corp. Business Overview
Table 146. Jei Daniel Biotech Corp. Product
Table 147. Jei Daniel Biotech Corp. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 148. Jei Daniel Biotech Corp. Recent Development
Table 149. Labor Diagnostika Nord Gmbh & Co. Kg Company Details
Table 150. Labor Diagnostika Nord Gmbh & Co. Kg Business Overview
Table 151. Labor Diagnostika Nord Gmbh & Co. Kg Product
Table 152. Labor Diagnostika Nord Gmbh & Co. Kg Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 153. Labor Diagnostika Nord Gmbh & Co. Kg Recent Development
Table 154. Micropoint Bioscience Inc. Company Details
Table 155. Micropoint Bioscience Inc. Business Overview
Table 156. Micropoint Bioscience Inc. Product
Table 157. Micropoint Bioscience Inc. Revenue in Radioimmunoassays Business (2015-2020) (Million US$)
Table 158. Micropoint Bioscience Inc. Recent Development
Table 159. Research Programs/Design for This Report
Table 160. Key Data Information from Secondary Sources
Table 161. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Radioimmunoassays Market Share by Type: 2020 VS 2026
Figure 2. Balance Method Features
Figure 3. Sequential Saturation Method Features
Figure 4. Global Radioimmunoassays Market Share by Application: 2020 VS 2026
Figure 5. Pharmaceutical Case Studies
Figure 6. Medical Testing Case Studies
Figure 7. Onology Case Studies
Figure 8. Others Case Studies
Figure 9. Radioimmunoassays Report Years Considered
Figure 10. Global Radioimmunoassays Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Radioimmunoassays Market Share by Regions: 2020 VS 2026
Figure 12. Global Radioimmunoassays Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Radioimmunoassays Market Share by Players in 2019
Figure 15. Global Top Radioimmunoassays Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radioimmunoassays as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Radioimmunoassays Revenue in 2019
Figure 17. North America Radioimmunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Radioimmunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Radioimmunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Radioimmunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Radioimmunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Radioimmunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Radioimmunoassays Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Bottom-up and Top-down Approaches for This Report
Figure 25. Data Triangulation
Figure 26. Key Executives Interviewed